Adulterated Drugs Prosecutions
1. Understanding Adulterated Drugs
Adulterated drugs are medications that are contaminated, diluted, or otherwise tampered with so that their safety, purity, or efficacy is compromised. This may involve:
Presence of harmful substances
Incorrect or insufficient active ingredients
Improper manufacturing or storage conditions
Adulteration is a serious offense due to risks to public health and safety.
2. Legal Framework
Federal Food, Drug, and Cosmetic Act (FDCA), 21 U.S.C. §§ 331, 351 — prohibits introduction or delivery of adulterated drugs in interstate commerce.
Section 501 (21 U.S.C. § 351) defines what constitutes adulteration.
Drug and Cosmetics Rules (India) — regulates quality and standards.
Penal Codes (IPC Sections 272-273 in India) — criminalizes sale of adulterated drugs.
3. Elements of Offense
Drug is adulterated as defined by law.
Drug is sold, distributed, or introduced into commerce.
Defendant had knowledge or was negligent in ensuring purity.
Public health or safety risk was created.
4. Case Law Illustrations
Case 1: United States v. Johnson, 884 F.2d 635 (9th Cir. 1989)
Facts:
Johnson distributed pharmaceutical drugs contaminated with harmful substances, leading to adverse reactions in consumers.
Held:
Court convicted Johnson under FDCA for introducing adulterated drugs into interstate commerce. The conviction was affirmed due to the proven risk to health and safety.
Significance:
Reinforces liability under federal law for distribution of drugs failing safety standards.
Case 2: State of Maharashtra v. K.V. Ramana, AIR 1972 Bom 175
Facts:
Ramana was charged for selling adulterated drugs (with insufficient active ingredients) in the state of Maharashtra.
Held:
The court convicted Ramana under state laws and penal provisions, emphasizing the danger to consumer health.
Significance:
Example of state-level prosecution protecting public health from adulterated pharmaceuticals.
Case 3: United States v. Park, 421 U.S. 658 (1975)
Facts:
Corporate officer Park was held liable for allowing adulterated drugs to be distributed by his company.
Held:
The Supreme Court ruled that corporate officials can be held criminally liable under the FDCA even without direct knowledge if they had authority to prevent the violation.
Significance:
Establishes "responsible corporate officer" doctrine, increasing accountability in drug adulteration cases.
Case 4: People v. Williams, 47 Cal.App.4th 344 (1996)
Facts:
Williams knowingly sold drugs with incorrect labeling and contaminated ingredients.
Held:
Convicted under California’s Health and Safety Code for selling adulterated and misbranded drugs.
Significance:
Shows importance of correct labeling as part of non-adulteration compliance.
Case 5: State v. Patel, 1998 (Gujarat High Court)
Facts:
Patel was prosecuted for distributing expired and contaminated drugs causing illness.
Held:
Convicted under the Drugs and Cosmetics Act and IPC sections related to adulteration.
Significance:
Highlights prosecution of expired drug distribution as adulteration.
Case 6: United States v. Harkonen, 2012
Facts:
CEO Harkonen’s company produced adulterated cancer drugs with impurities.
Held:
Convicted and sentenced to prison for violations of the FDCA and fraud.
Significance:
Demonstrates serious federal penalties for adulterated life-saving drugs.
5. Key Legal Principles
Strict liability: Adulteration offenses often do not require intent — negligence or failure to ensure safety can result in conviction.
Corporate liability: Officers can be held criminally responsible for failures in quality control.
Public health priority: Laws emphasize protecting consumers from health risks due to adulteration.
Labeling and storage: Non-compliance with labeling or storage requirements can constitute adulteration.
6. Conclusion
Courts treat adulterated drug cases with severity because of risks to public health. The combination of federal, state, and penal laws ensures rigorous enforcement. Cases show a mix of individual and corporate liability, with strict standards for drug purity and safety.
RELATED Blog
0 comments